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Modern scientific technology has provided a new class of large-
scale simultaneous inference problems, with thousands of hypothe-
sis tests to consider at the same time. Microarrays epitomize this
type of technology, but similar situations arise in proteomics, spec-
troscopy, imaging, and social science surveys. This paper uses false
discovery rate methods to carry out both size and power calculations
on large-scale problems. A simple empirical Bayes approach allows
the false discovery rate (fdr) analysis to proceed with a minimum of
frequentist or Bayesian modeling assumptions. Closed-form accuracy
formulas are derived for estimated false discovery rates, and used to
compare different methodologies: local or tail-area fdr’s, theoretical,
permutation, or empirical null hypothesis estimates. Two microarray
data sets as well as simulations are used to evaluate the methodology,
the power diagnostics showing why nonnull cases might easily fail to
appear on a list of “significant” discoveries.
1. Introduction. Large-scale simultaneous hypothesis testing problems,
with hundreds or thousands of cases considered together, have become a
familiar feature of current-day statistical practice. Microarray methodology
spearheaded the production of large-scale data sets, but other “high through-
put” technologies are emerging, including time of flight spectroscopy, pro-
teomic devices, flow cytometry and functional magnetic resonance imaging.
Benjamini and Hochberg’s seminal paper [3] introduced false discovery
rates (Fdr), a particularly useful new approach to simultaneous testing. Fdr
theory relies on p-values, that is on null hypothesis tail areas, and as such
operates as an extension of traditional frequentist hypothesis testing to si-
multaneous inference, whether involving just a few cases or several thou-
sand. Large-scale situations, however, permit another approach: empirical
Bayes methods can bring Bayesian ideas to bear without the need for strong
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Fig. 1. Histograms of z values from two microarray experiments. Left panel, prostate
data, comparison of 50 nontumor subjects with 52 tumor patients for each of 6033 genes;
Singh et al. [31]. Right panel, HIV data, comparison of 4 HIV negative subjects with 4
HIV positive patients for 7680 genes; van’t Wout et al. [34], discussed in [16]. The central
peak of the prostate data histogram closely follows the theoretical N(0,1) null density (solid
curve), but the HIV histogram is substantially too narrow. Short vertical bars are estimated
nonnull counts, useful for power calculations, as discussed in Section 3. Estimated null
proportion p0 equals 0.93 in both experiments.
Bayesian or frequentist assumptions. This paper pursues large-scale false
discovery rate analysis from an empirical Bayes point of view, with the goal
of providing a versatile methodology for both size and power considerations.
The left panel of Figure 1 concerns a microarray example we will use
to introduce our main ideas. 102 microarrays, 50 from nontumor subjects
and 52 from prostate cancer patients, each measured expression levels for
the same N = 6033 genes. Each gene yielded a two-sample t-statistic ti
comparing tumor versus nontumor men, which was then transformed to a z
value,
zi =Φ
−1(F100(ti)),(1.1)
where F100 is the cumulative distribution function (c.d.f.) of a Student’s t
distribution with 100 degrees of freedom, and Φ is the standard normal c.d.f.
We expect zi to have nearly a N(0,1) distribution for “null” genes, the
ones behaving similarly in tumor and nontumor situations. The left his-
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togram looks promising in this regard: its large central peak, which is nicely
proportional to a N(0,1) density, charts the presumably large majority of
null genes, while the heavy tails suggest some interesting “nonnull” genes,
those responding differently in the two situations, the kind the study was
intended to detect.
Note. It is not necessary that the zi’s be obtained from t-tests or that
the individual cases correspond to genes. Each of the N cases might involve
a separate linear regression for example, with the ith case yielding p-value
pi for some parameter of interest, and zi =Φ
−1(pi).
Section 2 reviews Fdr theory with an emphasis on the local false discovery
rate, defined in a Bayesian sense as
fdr(zi) = Prob{gene i is null|zi = z}.(1.2)
An estimate of Fdr (z) for the prostate data is shown by the solid curve in
Figure 2, constructed as in Section 2, where it is suggested that a reasonable
threshold for reporting likely nonnull genes is fdr(zi) ≤ 0.2. 51 of the 6033
genes have fdr≤ 0.2, 25 on the left and 26 on the right. A list of these genes
could be reported to the investigators with assurances that it contains less
than 20% null cases. Here fdr methods are being used to control size, or
Type I errors.
The solid bars in Figures 1 and 2 are estimates of the nonnull histogram,
what we would see if we had z values only for the nonnull genes, constructed
as in Section 3. Combined with the fdr curve, the nonnull histogram helps
assess power, the ability of the data to identify nonnull genes. Figure 2
suggests low power for the prostate data: most of the nonnull cases have
large values of fdr (zi), and cannot be reported on a list of interesting genes
without also reporting a large percentage of null cases. Section 3 constructs
some simple power diagnostics based on fdr considerations.
Following [3], most of the Fdr literature has focussed on tail area false
discovery rates,
Fdr(zi) = Prob{gene i is null|zi ≤ z}(1.3)
(or Prob{null|zi ≥ z} depending on the sign of z). Section 2 discusses the
relationship of fdr to Fdr, with relative efficiency calculations presented in
Section 5. Local fdr’s fit in better with empirical Bayes development, and
are featured here, but most of the ideas apply just as well to tail area Fdr’s.
The discussion in Sections 2 and 3 assumes that the appropriate null dis-
tribution is known to the statistician, perhaps being the theoretical N(0,1)
null suggested by (1.1), or its permutation-based equivalent [also nearly
N(0,1) for both data sets in Figure 1]. This is tenable for the prostate
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Fig. 2. Local false discovery rate fdr(z), (1.2) for prostate data, solid curve. 51 genes,
25 on the left and 26 on the right, have fdr(zi)≤ 0.2, a reasonable threshold for reporting
nonnull cases. Solid bars show estimated nonnull histogram (plotted negatively, divided by
50), constructed as in Section 3. Most of the nonnull cases will not be reported.
data, but not for the HIV data. Sections 4 and 5 consider the more difficult
and common large-scale testing situation where there is evidence against
the theoretical null. Efron [8, 9, 10] discusses estimating an empirical null
in situations like that for the HIV data where the central histogram does
not match N(0,1). Some methodology for constructing empirical nulls is
described in Section 4, and its efficiency investigated in Section 5. [It gives
empirical null N(−0.011,0.752) for the HIV data, as shown in Figure 1.]
Three pairs of related ideas are considered here:
• Size and power calculations for large-scale simultaneous testing.
• Local and tail-area false discovery rates.
• Theoretical and empirical null hypotheses.
All combinations are possible, a power analysis using local fdr with a the-
oretical null distribution for instance, but only a few are illustrated in the
text.
A substantial microarray statistics literature has developed in the past
few years, much of it focused on the control of frequentist Type I errors; see,
for example, [7], and the review article by Dudoit, Shaffer and Boldruck [6].
Bayes and empirical Bayes methods have also been advocated, as in [18, 19]
and [27], while Benjamini and Hochberg’s Fdr theory is increasingly influ-
ential; see [15] and [33]. Lee et al. [22] and Kerr, Martin and Churchill [20]
discuss large-scale inference from ANOVA viewpoints. Local fdr methods,
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which this article argues can play a useful role, were introduced in [14]; sev-
eral references are listed at the end of Section 2. The paper ends with a brief
summary in Section 6.
2. False discovery rates. Local false discovery rates [13, 14], are a variant
of [3] “tail area” false discovery rates. This section relates the two ideas,
reviews a few basic properties, and presents some general guidelines for
interpreting fdr’s.
Suppose we have N null hypotheses to consider simultaneously, each with
its own test statistic,
Null hypothesis: H1,H2, . . . ,Hi, . . . ,HN ,
(2.1)
Test statistic : z1, z2, . . . , zi, . . . , zN ;
N must be large for local fdr calculations, at least in the hundreds, but the zi
need not be independent. (At least not for getting consistent Fdr estimates,
though correlations can decrease the accuracy of such estimates, as detailed
in Section 5.) A simple Bayesian “two-class” model, [14, 22, 26], underlies
the theory: we assume that the N cases are divided into two classes, null or
nonnull, occurring with prior probabilities p0 or p1 = 1− p0, and with the
density of the test statistic z depending upon its class,
p0 =Pr{null}, f0(z) density if null,
(2.2)
p1 =Pr{nonnull}, f1(z) density if nonnull.
It is natural to take f0(z) to be a standard N(0,1) density in context (1.1),
the theoretical null. Here and in Section 3 we assume that f0(z) is known
to the statistician, deferring until Section 4 its estimation in situations like
that for the HIV data where the theoretical null is not believable. Fdr theory
does not require specification of f1(z), which is only assumed to be longer-
tailed than f0(z), with the nonnull zi’s tending to occur farther away from
0. Proportion p0, the Bayes a priori probability of a gene being null, is also
supposed known here, its estimation being discussed in Sections 4 and 5.
Practical applications of large-scale testing usually assume p0 large, say
p0 ≥ 0.9,(2.3)
the goal being to identify a relatively small set of interesting nonnull cases.
Under assumption (2.3), p0 has little practical effect on the usual false dis-
covery rate calculations, that is, on the control of Type I errors, but it will
become more crucial for the power diagnostics of Section 3.
Define the null subdensity
f+0 (z) = p0f0(z)(2.4)
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Fig. 3. Geometrical relationship of Fdr to fdr; heavy curve plots F+0 (z) versus F (z);
fdr(z) is slope of tangent, Fdr(z) slope of secant.
and the mixture density
f(z) = p0f0(z) + p1f1(z).(2.5)
The Bayes posterior probability that a case is null given z, by definition the
local false discovery rate, is
fdr(z)≡ Pr{null|z}= p0f0(z)/f(z) = f+0 (z)/f(z).(2.6)
The Benjamini–Hochberg false discovery rate theory relies on tail areas
rather than densities. Letting F0(z) and F1(z) be the c.d.f.’s corresponding
to f0(z) and f1(z) in (2.2), define F
+
0 (z) = p0F0(z) and F (z) = p0F0(z) +
p1F1(z). Then the posterior probability of a case being null given that its
z-value “Z” is less than some value z is
Fdr(z)≡ Pr{null|Z ≤ z}= F+0 (z)/F (z).(2.7)
(It is notationally convenient to consider events Z ≤ z but we could just
as well consider tail areas to the right, two-tailed events, etc.) Figure 3
illustrates the geometrical relationship between Fdr and fdr.
Analytically, Fdr is a conditional expectation of fdr [13],
Fdr(z) =
∫ z
−∞
fdr(Z)f(Z)dZ
/∫ z
−∞
f(Z)dZ
(2.8)
=Ef{fdr(Z)|Z ≤ z},
“Ef” indicating expectation with respect to f(z) [13]. That is, Fdr(z) is
the average of fdr(Z) for Z ≤ z; Fdr(z) will be less than fdr(z) in the usual
situation where fdr(z) decreases as |z| gets large. For example fdr(−3.39) =
SIZE, POWER AND FALSE DISCOVERY RATES 7
0.20 in Figure 2 while Fdr(−3.39) = 0.105. If the c.d.f.’s F0(z) and F1(z) are
Lehmann alternatives,
F1(z) = F0(z)
α [α < 1],(2.9)
it is straightforward to show that
log
{
fdr(z)
1− fdr(z)
}
= log
{
Fdr(z)
1− Fdr(z)
}
+ log
(
1
α
)
,(2.10)
giving
fdr(z)
.
=Fdr(z)/α(2.11)
for small values of Fdr. The prostate data of Figure 1 has α roughly 1/2 in
each tail.
Benjamini and Hochberg’s [3] Fdr control rule depends on an estimated
version of (2.7) where F (z) is replaced by the empirical c.d.f. “F¯” of the z
values,
F̂dr(z) = p0F0(z)/F¯0(z) [F¯ (z) =#{zi ≤ z}/N ].(2.12)
Storey [32] and Efron and Tibshirani [13] discuss the connection of the fre-
quentist Fdr control procedure with Bayesian form (2.7). Fdr(z) corresponds
to Storey’s “q-value,” the tail-area false discovery rate attained at a given
observed value zi = z. F̂dr(z) is biased upward as an estimate of Fdr(z); see
Section 4 of [13].
The estimated fdr curve in Figure 2 is
f̂dr(z) = p0f0(z)/f̂ (z),(2.13)
where f0(z) is the standard normal density ϕ(z) = exp{−z2/2}/
√
2x, p0 =
0.932 is the value derived in Section 4, and f̂(z) is a maximum likelihood es-
timate (MLE) of the mixture density f(z), (2.5), within the seven-parameter
exponential family described in Section 4. This type of flexible parametric
modeling takes advantage of the fact that f(z), as a mixture of null and
nonnull z values, tends to be quite smooth; see Section 6 of [9]. Lindsey’s
method, Lindsey [24, 25] described in Section 4, finds f̂(z) using standard
Poisson GLM software. The theory and simulations of Section 5 show only
a moderate cost in estimation variability for f̂dr compared to F̂dr.
A variety of other local fdr estimation methods have been suggested: us-
ing more specific parametric models such as normal mixtures, see [1, 28, 30]
or [17]; isotonic regression [4]; local smoothing [2]; and hierarchical Bayes
analyses [5, 23]. All seem to perform reasonably well. The Poisson GLM
methodology of this paper has the advantage of easy implementation with
familiar software, and permits a closed-form error analysis as shown in Sec-
tion 5.
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Classical frequentist hypothesis testing methods rely on tail areas by ne-
cessity. Large-scale testing situations allow us to do local calculations, which
are more natural from a Bayesian point of view. For example, the 25 prostate
data genes having zi ≤ −3.39 have q-value F̂dr(−3.39) = 0.105; they have
average f̂dr(zi) of about 0.105 [as in (2.8)], but varying from 0.20 at the
boundary point zi =−3.39 down to fdr(zi) = 0.01 at zi = −4.4. This just
says the obvious, that zi’s further from the boundary are less likely to be
false discoveries, which is the useful message conveyed by f̂dr(z). The power
diagnostics of Section 3 rely on the local Bayesian interpretation (2.6).
The literature has not reached consensus on a standard choice of q for
Benjamini–Hochberg testing, the equivalent of 0.05 for single tests, but
Bayesian calculations offer some insight. The cutoff threshold fdr ≤ 0.20
used in Figure 2 yields posterior odds ratio
Pr{nonnull|z}/Pr{null|z}= (1− fdr(z))/fdr(z)
(2.14)
= p1f1(z)/p0f0(z)≥ 0.8/0.2 = 4.
If we assume prior odds ratio p1/p0 ≤ 0.1/0.9 as in (2.3), then (2.12) corre-
sponds to the Bayes factor
f1(z)/f0(z)≥ 36(2.15)
in favor of nonnull.
This threshold requires a much stronger level of evidence against the null
hypothesis then in standard one-at-a-time testing, where the critical thresh-
old lies somewhere near 3 [11]. We might justify (2.15) as being conservative
in guarding against multiple testing fallacies. More pragmatically, increasing
the fdr threshold much above 0.20 can deliver unacceptably high proportions
of false discoveries to the investigators. The 0.20 threshold, used in the re-
mainder of the paper, corresponds to q-values between 0.05 and 0.15 for
reasonable choices of α in (2.11); such q-value thresholds can be interpreted
as reflecting a conservative Bayes factor for Fdr interpretation.
Any choice of threshold is liable to leave investigators complaining that
the statisticians’ list of nonnull cases omits some of their a priori favorites.
Conveying the full list of values fdr(zi), not just those for cases judged non-
null, allows investigators to employ their own prior opinions on interpreting
significance. This is particularly important for low-powered situations like
the prostate study, where luck plays a big role in any one case’s results, but
it is the counsel of perfection, and most investigators will require some sort
of reduced list.
The basic false discovery rate idea is admirably simple, and in fact does
not depend on the literal validity of the two-class model (2.2). Consider the
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28 genes in the prostate example that have zi ≥ 3.3; the expected number
of null genes having zi ≥ 3.3 is 2.71 [= 6033 · 0.932(1−Φ(3.3))], so
F̂dr = 2.71/28 = 0.097.(2.16)
The Fdr interpretation is that about one tenth of the 28 genes can be ex-
pected to be null, the other nine tenths being genuine nonnull discoveries.
This interpretation does not require independence, nor even all of the null
genes to have the same density f0(z), only that their average density behaves
like f0. Since the denominator 28 is observed, the nonnull density f1(z) plays
no role. Exchangeability of the 28 cases is the only real assumption, coming
into play when we report that each of the 28 genes has the same one tenth
probability of being null. The local fdr has an advantage here, since the
equivalent exchangeability assumption is made only for genes having the
same observed z values. These ideas are examined in Section 4 of [13].
3. Power diagnostics. The microarray statistics literature has focussed
on controlling Type I error, the false rejection of genuinely null cases. Dudoit,
van der Laan and Pollard [7] provides a good review. Local fdr methods
can also help assess power, the probability of rejecting genuinely nonnull
cases. This section discusses power diagnostics based on f̂dr(z), showing,
for example, why the prostate study might easily fail to identify important
genes. The emphasis here is on diagnostic statistics that are dependable and
simple to calculate.
The nonnull density f1(z) in the two-class model (2.2), unimportant for
the “size” calculations of Section 2, plays a central role in assessing power.
From (2.5) and (2.6) we obtain
p1 =
∫ ∞
−∞
[1− fdr(z)]f(z)dz = 1− p0(3.1)
and
f1(z) = (1− fdr(z))f(z)/p1.(3.2)
An estimate of f(z) gives f̂dr(z) as in (2.13), and then the estimated nonnull
density
f̂1(z) = [1− f̂dr(z)]f̂ (z)
/∫ ∞
−∞
[1− f̂dr(z′)]f̂(z′)dz′.(3.3)
Power diagnostics are obtained from the comparison of f̂1(z) with f̂dr(z).
The expectation of f̂dr under f̂1, say “Êfdr1,” provides a particularly simple
diagnostic statistic,
Êfdr =
∫ ∞
−∞
f̂dr(z)[1− f̂dr(z)]f̂ (z)dz/
∫ ∞
−∞
[1− f̂dr(z)]f̂(z)dz.(3.4)
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A small value of Êfdr1, perhaps Êfdr1
.
= 0.20, suggests good power, with
a typical nonnull gene likely to show up on a list of interesting candidates
for further study. Neither of the examples in Figure 1 demonstrates good
power; Êfdr1 = 0.68 for the prostate data and 0.47 for the HIV data (the
latter based on the empirical null f̂dr estimate of Section 4).
The nonnull counts pictured in Figures 1 and 2 allow a more intuitive in-
terpretation of formula (3.4). Suppose that the N z-values have been placed
into K bins of equal width ∆, with
xk = centerpoint of kth bin for k = 1,2, . . . ,K,
(3.5)
yk =#{zi in kth bin}.
Since
Prob{gene i nonnull|zi = z}= 1− fdr(z),(3.6)
an approximately unbiased estimate of the nonnull counts in bin k is
ŷ1k = [1− f̂dr(xk)] · yk.(3.7)
The solid bars in Figures 1 and 2 follow definition (3.7), except with yk
replaced by a smoothed estimate proportioned to f̂(xk). Looking at Figure 2,
an obvious estimate of the nonnull expectation Efdr1 is
Êfdr1 =
∑
k f̂dr(xk) · ŷ1k∑
k ŷ1k
=˙
∑
k f̂dr(xk)[1− f̂dr(xk)]f̂(xk)∑
k[1− f̂dr(xk)]f̂(xk)
,(3.8)
which amounts to evaluating the integrals in (3.4) via the trapezoid rule.
Table 1 reports on a simulation study of Êfdr1. The study took
zi
ind∼ N(µi,1) with
{
µi = 0, probability 0.90,
µi ∼N(3,1), probability 0.10,(3.9)
for i = 1,2, . . . ,N = 1500. [More precisely, µi = 3 + Φ
−1((i− 0.5)/150), i=
1,2, . . . ,150, for the nonnull cases.] The “theoretical null” columns assume
f0 = N(0,1), while “empirical null” estimates f0 by the central matching
method of Section 4. Both methods estimated p̂1 = 1− p̂0 by central matches.
The true value of Efdr1 in situation (3.9) is 0.32. The estimates Êfdr1 are
seen to be reasonably stable and roughly accurate. Section 5 discusses the
downward bias in p̂1.
Going further, we can examine the entire distribution of f̂dr under f̂1
rather than just its expectation. The nonnull c.d.f. of f̂dr is estimated by
Ĝ1(t) =
∑
k : f̂dr(xk)≤t
ŷ1k/
∑
k
ŷ1k(3.10)
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Table 1
Means, standard deviations and coefficients of variation of Êfdr1 (3.5); 100 trials of
situation (3.9), N = 1500. True value Efdr1 = 0.32, p1 = 0.10
Theoretical null Empirical null
Êfdr1 p̂1 Êfdr1 p̂1
Mean 0.285 0.085 0.232 0.076
Stdev 0.060 0.015 0.040 0.011
Coefvar 0.21 0.18 0.17 0.14
for 0≤ t≤ 1. Figure 3 shows Ĝ1(t) for the prostate study, for the HIV study
[taking f0 =N(−0.11,0.752), p0 = 0.93, as in Figure 1], and for the first of
the 100 simulations from model (3.9). The simulation curve suggests good
power characteristics, with 64% of the nonnull genes having fdr less than 0.2.
At the opposite extreme, only 11% of nonnull genes in the prostate study
have fdr less than 0.2.
Graphs such as Figure 4 help answer the researchers’ painful question
“why are not the genes we expected on your list of nonnull outcomes?” For
the prostate data, most of the nonnull genes will not turn up on a list of
low fdr cases. The R program locfdr, discussed in Section 4, returns Êfdr1
and a graph of Ĝ1(t).
Traditional sample size calculations employ preliminary data to predict
how large an experiment might be required for effective power. Here we
might ask, for instance, if doubling the number of subjects in the prostate
study would substantially improve its detection rate.
To answer this question, denote the mean and variance of zi by µi and
σ2i ,
zi ∼ (µi, σ2i ).(3.11)
We imagine that c independent replicates of zi are available for each gene
(doubling the experiment corresponding to c= 2), from which a combined
test statistic z˜i is formed,
z˜i =
c∑
j=1
zij/
√
c∼ (√cµi, σ2i ).(3.12)
This definition maintains the mean and variance of null cases, z˜i ∼ (0, σ2i ),
while moving the nonnull means µ˜i =
√
cµi away from zero by the factor
√
c.
Consider a subset of m nonnull genes, say S , and define
µ¯=
∑
S
µi/m, ∆
2 =
∑
S
(µi − µ¯)2/m and σ¯2 =
∑
S
σ2i /m.(3.13)
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Fig. 4. Estimated nonnull c.d.f. of fdr, (3.10); prostate study, HIV study, and first of
100 simulations, model (3.9). The simulation curve suggests substantial power, with 64%
of the nonnull cases having f̂dr less than 0.2. Êfdr1 values: 0.23 (simulation), 0.45 (HIV),
0.68 (prostate).
A randomly selected zi value “Z” from S has mean and variance
Z ∼ (µ¯,∆2 + σ¯2),(3.14)
while Z˜, the corresponding randomly selected z˜i value, has
Z˜ ∼ (√cµ¯, c∆2 + σ¯2),(3.15)
so
Z˜ =
√
c µ¯+ d(Z − µ¯) [d2 = c− (c− 1)σ¯2/(∆2 + σ¯2)](3.16)
gives Z˜ the correct mean and variance.
Let S be the set of nonnull genes having zi > 0. We can estimate µ¯ and
d from the corresponding nonnull counts ŷ1k (the bars to the right of z = 0
in Figure 2), and then use (3.16) to move those counts out from location xk
to x˜k =
√
c{µ¯+ d1/2(xk − µ¯)}. The null counts ŷ0k = yk − ŷ1k do not change
location when the sample size increases. We can do the same calculations
for the nonnull counts having zi < 0. Together, these provide an estimate of
what the entire z-value histogram would look like if the sample size were
increased by the factor c, from which we can recalculate Êfdr1 or any other
diagnostic statistic.
Table 2 shows Êfdr1 estimates for hypothetical expansions of the prostate
and HIV studies. Doubling the HIV study, to 8 instead of 4 subjects in each
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Table 2
Hypothetical values of Êfdr1 for versions of the prostate and HIV studies expanded by
factor c; based on transformation (3.17) for the nonnull counts, as calculated by R
program locfdr
c 1 1.5 2 2.5 3
Prostate 0.68 0.54 0.44 0.38 0.34
HIV 0.45 0.31 0.23 0.18 0.14
HIV category, reduces Êfdr1 from 0.45 to 0.23, while doubling the prostate
study gives less dramatic improvement. Table 2 is based on a cruder version
of (3.16) that takes d= 1,
Z˜ =
√
cZ,(3.17)
in other words, simply moving the nonnull counts ŷ1k from xk to
√
cxk.
Using (3.17) tends to underestimate the reduction in Êfdr1, but did not
make much difference in this case.
The R program locfdr does these calculations. They have a speculative
nature, but no more so than traditional power projections. Like all of the di-
agnostics in this section, they require no mathematical assumptions beyond
the original two-class model (2.2).
4. Empirical null estimation. The null density f0(z) in (2.2) is crucial to
false discovery rate calculations, or for that matter to any hypotheses test-
ing method. We assumed f0 ∼N(0,1), the theoretical null, for the prostate
data. This seems natural in situation (1.1), being almost certainly what
would be done if there were only a single gene’s data to analyze. Large scale
simultaneous testing, however, raises the possibility of detecting deficien-
cies in the theoretical null, as with the HIV data in Figure 1 where the
z-value histogram is noticeably too narrow around its central peak. This
section concerns data-based estimates of f0(z), for example, the empirical
null distribution f̂0 ∼N(−0.11,0.752) for the HIV data, shown in Figure 1.
Efron [8, 10] lists four reasons why f0 might differ from the theoretical
null:
(1) Failed assumptions. Let Y be the N by n matrix of expression levels,
N genes and n microarrays in our two studies,
yij = expression level for ith gene and jth array.(4.1)
The HIV study has N = 7680 genes and n = 8 microarrays, 4 each from
HIV positive and HIV negative subjects. Each gene yields a two-sample t
statistic ti comparing positive versus negative subjects, with z-value
zi =Φ
−1(F6(ti)),(4.2)
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F6 the c.d.f. of a t distribution having 6 degrees of freedom.
The theoretical null distribution f0 ∼N(0,1) is justified for (4.2) if the
yij ’s are normal, or by asymptotic theory as n goes to infinity, neither ar-
gument applying to the HIV data. We can avoid these assumptions by com-
puting a permutation null, the marginal distribution of the zi’s obtained by
permuting the columns of Y . This gave f̂0∼˙N(0,0.992) for the HIV data,
failing to explain the narrow central peak in Figure 1.
(2) Unobserved covariates. The HIV study is observational: subjects were
observed, not assigned to be HIV positive or negative, and similarly for
the prostate study. Section 4 of [8] discusses how unobserved covariates in
observational studies are likely to widen f0(z), and how this effect is not
detectable by permutation analysis. A microarray example is presented in
which the z-value histogram has central dispersion more than half again as
wide as the theoretical null. Since the HIV histogram is too narrow at its
center rather than too wide, unobserved covariates are not the problem here.
(3) Correlation across arrays. The theoretical null as applied to (4.2) or
(1.1) assumes independence across the columns of Y , that is, among yi1, yi2,
. . . , yin for gene i. Experimental difficulties can undercut independence in
microarray studies, while being undetectable in the permutation null distri-
bution. The HIV data was analyzed with the HIV negative subjects as the
first four columns of Y and the positives as the last four columns. A prin-
cipal components analysis suggested a strong pattern of correlation across
columns, with arrays (1,3,5,7) positively correlated, and likewise arrays
(2,4,6,8). This pattern would narrow the null distribution in situation (4.2).
(4) Correlation between genes. A striking advantage of the two-group
model and its false discovery rate analysis in Section 2 is that it does not re-
quire independence between genes. Estimates such as f̂dr(z) = p0f0(z)/f̂ (z)
only require consistency for f̂(z) (but do not achieve the full efficiency at-
tainable from knowledge of the gene-wise correlation structure).
Efron [10] emphasizes a caveat to this argument: even if the theoretical
null is individually appropriate for each null gene, correlations between genes
can make the effective null distribution f0(z) substantially narrower or wider
than N(0,1). There it is shown that the amount of correlation in the HIV
data could easily explain a N(−0.11,0.752) null distribution. (By contrast,
the prostate data exhibits quite small gene-wise correlations.) A permutation
null distribution will not reveal correlation effects.
Empirically estimating the null distribution avoids all four difficulties, and
any others that may distort f0. There is a price to pay, though, in terms of
accuracy: using the empirical null substantially increases the variability of
estimated false discovery rates, as shown in Section 5. This price is unavoid-
able in situations like the HIV study where there is clear evidence against
the theoretical null; the null distribution provides the crucial numerator in
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false discovery rate estimates like (2.16), where using an inappropriate null
undercuts inferential validity. (Using the theoretical null on the HIV data
eliminates all but 20 of the 151 genes having empirical null f̂dr estimate less
than 0.20, including all of those with zi < 0.)
The basic empirical null idea is simple: we assume f0(z) is normal but
not necessarily with mean 0 and variance 1, say
f0(z)∼N(δ0, σ20),(4.3)
and then estimate δ0, σ0, as well as the null proportion p0 in (2.2), from the
histogram data near z = 0. Two different methods for estimating (δ0, σ0, p0)
will be described, and their accuracies analyzed in Section 5. Both methods
are implemented in algorithm locfdr, available through the Comprehensive
R Archive Network, http://cran.r-project.org; locfdr produced all of
the numerical examples in this paper.
“Central matching,” the first of our two estimation methods for (δ0, σ0, p0),
operates by quadratically approximating log f̂(z) around z = 0. To begin, the
locfdr algorithm estimates f(z), (2.5), by maximum likelihood fitting to the
histogram counts yk for the z values, (3.5), within a parametric exponential
family. Figure 2 used the seven-parameter family
fβ(z) = cβ exp
{
7∑
j=1
βjz
j
}
,(4.4)
cβ the constant making fβ integrate to 1.
Figure 5 illustrates central matching estimation of (δ0, σ0, p0) for the HIV
data based on the methodology in [8]. The heavy curve is log f̂(z), fit by
maximum likelihood [using a natural spline basis with 7 degrees of freedom,
rather than the polynomials of (4.4), another option in locfdr, though (4.4)
gives nearly identical results in this case]. A quadratic curve f̂+0 (z) has been
fit to log f̂(z) around z = 0,
log(f̂+0 (z)) = β̂0 + β̂1z + β̂2z
2.(4.5)
Assuming f0(z)∼N(δ0, σ20), the log of the null subdensity (2.4) is
log(f+0 (z)) = log p0 −
1
2
{
δ20
σ20
+ log(2πσ20)
}
+
δ0
σ20
z − 1
2σ20
z2.(4.6)
Estimates (β̂0, β̂1, β̂2) from (8.5) translate to estimates (δ̂0, σ̂0, p̂0) in (4.6),
for example, σ̂0 = (2β̂2)
−1/2. For the HIV data this gave
δ̂0 =−0.107, σ̂0 = 0.753 and p̂0 = 0.931.(4.7)
The logic here is straightforward: we make the “zero assumption” that
the central peak of the z-value histogram consists mainly of null cases,
16 B. EFRON
Fig. 5. Central matching estimation of p0 and f0(z)∼N(δ0, σ
2
0) for the HIV data; heavy
curve is log of f̂(z), estimated mixture density (2.5); beaded curve is quadratic fit to log f̂(z)
around z = 0, estimating log f+0 (z), (2.4). The three estimated coefficients of quadratic fit
give (δ̂0, σ̂0, p̂0).
and choose (δ0, σ0, p0) in (4.6) to quadratically approximate the histogram
counts near δ = 0. Some form of the zero assumption is required because the
two-class model (2.2) is unidentifiable in the absence of strong parametric
assumptions on f1.
A healthy literature exists on estimating p0, as in [21] and [29], all of
which relies on the zero assumption [mostly working with p-values rather
than z-values, e.g., pi = F6(ti) in (4.2), where the “zero region” occurs near
p= 1]. All of this literature relies on the validity of the theoretical null, so in
this sense (4.5) and (4.6) is a straightforward extension to situations where
the theoretical null is untrustworthy. For the HIV data, using the theoretical
null in (4.5) and (4.6), that is, taking (β̂1, β̂2) equal (0,1/2), results in the
impossible estimate p̂0 = 1.18. This will always happen when the z-value
histogram is narrower than N(0,1) near z = 0.
The zero assumption is more believable if p0, the proportion of null cases,
is large. Efron [8] shows that if p0 exceeds 0.90 the fitting method in Figure
5 will be nearly unbiased: although the 10% or less of nonnull cases might
in fact contribute some counts near z = 0, they cannot substantially affect
δ̂0 and σ̂0; the p0 estimate is affected, being upwardly biased, as seen in
Table 1.
“MLE fitting,” the second, newer, method of estimating (δ0, σ0, p0), is
based on a truncated normal model. We assume that the nonnull density is
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supported outside some known interval [−x0, x0],
f1(z) = 0 for z ∈ [−x0, x0].(4.8)
We need the following definitions:
I0 = {i : zi ∈ [−x0, x0]},
N0 = number of zi ∈ [−x0, x0],
(4.9)
z0 = {zi, i ∈ I0},
H0(δ0, σ0) = Φ
(
x0 − δ0
σ0
)
−Φ
(−x0 − δ0
σ0
)
and
ϕδ0,σ0(z) =
1√
2πσ20
exp
{
−1
2
(
z − δ0
σ0
)2}
.(4.10)
Then
θ ≡ p0H0(δ0, σ0) = Prob{zi ∈ [−x0, x0]}(4.11)
under model (2.2).
The likelihood function of the data (N,z0) is
fδ0,σ0,p0(N,z0) = [θ
N0(1− θ)N−N0]
[∏
I0
ϕδ0,σ0(zi)
H0(δ0, σ0)
]
.(4.12)
This is a product of two exponential family likelihoods, as discussed in Sec-
tion 5. It is easy to numerically find the MLE estimates (δ̂0, σ̂0, θ̂) in (4.12),
after which
p̂0 = θ̂/H0(δ̂0, σ̂0).(4.13)
Table 3 compares the estimates (δ̂0, σ̂0, p̂0) obtained from central matching
and MLE fitting for the same 100 simulations of model (3.9) used in Table 1.
MLE fitting does somewhat better overall, especially for δ̂0, the mean of f̂0.
The results are encouraging, in particular showing that σ0 can be estimated
within a few per cent. Delta method formulas for the standard deviations
are developed in Section 5. These performed well, giving nearly the correct
average values, as shown in the table, with small coefficient of variation
across the 100 simulations, about 10% for central matching and 3% for
MLE fitting. Changing sample size N = 1500 by multiple “c” changes the
standard deviations by about 1/
√
c.
The zi’s are independent in model (3.9). This is unrealistic for microarray
studies, but as discussed in Section 5, the results may still be applicable to
highly correlated situations.
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Table 3
Comparison of estimates (δ̂0, σ̂0, p̂0), central matching and MLE fitting; 100 simulations,
model (3.9), as in Table 1. MLE fitting took x0 = 2 in (4.8); “formula” standard
deviations from delta method calculations, Section 5. True values (δ0, σ0, p0) = (0,1,0.9)
Central matching MLE fitting
mean stdev (formula) mean stdev (formula)
δ̂0 0.021 0.056 (0.062) 0.044 0.031 (0.032)
σ̂0 1.020 0.029 (0.033) 1.035 0.031 (0.031)
p̂0 0.924 0.013 (0.015) 0.933 0.009 (0.011)
The two fitting methods have different virtues and defects. Central match-
ing is attractive from a theoretical point of view, suggesting how we might
go beyond normality assumption (4.3), as discussed in Section 7 of [9]. As
mentioned before, it gives nearly unbiased estimates of δ̂0 and σ̂0 if p0 ex-
ceeds 0.9. However, it can be excessively variable, especially in estimating
δ0, and is sensitive to the range of discretization (though not the grid size
∆) in (3.5); reducing the range of xk in Table 3 from [−4,7.4] to [−4,6.1]
gave notably worse performance.
MLE fitting generally gives more stable parameter estimates, for reasons
suggested by the influence function analysis of Section 5. It does not require
discretization of the z-values. It does, however, depend strongly on the choice
of x0 in (4.8), which was arbitrarily set at x0 = 2 in the simulations. A more
adaptive version that began by estimating an appropriate “zero assumption”
interval is feasible but more variable. This contrasts with central matching,
which automatically adjusts to each situation, including ones where (δ0, σ0)
is far from (0,1).
Locfdr defaults to MLE fitting for fdr estimation, but also returns the
central matching estimates. The two methods gave similar results for the
HIV data, (δ̂0, σ̂0, p̂0) = (−0.117,0.785,0.955) for MLE fitting, compared to
(4.7).
Accurate estimation of (δ0, σ0, p0) is just as important for tail-area Fdr
analysis (2.7) as for the local version (2.6). Section 5 computes the accuracy
of both F̂dr(z) and f̂dr(z). Using an empirical null is expensive in either
venue, but the theoretical null can be an unrealistic option, as for the HIV
data.
Permutation methods are popular in the microarray literature, but they
only address the first of our four listed difficulties for the theoretical null; in
practice permutation null distributions are usually close to the theoretical
distribution, especially for t-test statistics. Permutation and empirical null
methods can be used together: if F˜ (t) is the permutation c.d.f. for the t-
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statistics in the HIV study, then we could set zi = Φ
−1(F˜ (t)) rather than
(4.2) to begin empirical null estimation.
5. Influence and accuracy. Two different classifications of false discov-
ery rate methods have been discussed: local versus tail area definitions, Sec-
tion 2, and theoretical versus empirical null estimates, Section 4. This section
derives accuracy formulas for all four combinations, based on closed-form in-
fluence functions. In Figure 2, for example, the R algorithm locfdr reports
f̂dr(3.37) = 0.2±0.02 for the theoretical null and local fdr combinations, the
standard error 0.02 coming from Theorem 1 below. The influence functions
also help explicate differences between central matching and MLE fitting
estimation for the empirical null.
For numerical calculations it is convenient to assume that the N z-values
have been binned as in (3.5): into K bins of width ∆, centerpoint xk, for
k = 1,2, . . . ,K, with yk the count in bin k. “Lindsey’s method,” as discussed
in Section 2 of [12], then permits almost fully efficient parametric density
estimation within exponential families such as (4.4), using standard Poisson
regression software.
Locfdr first fits an estimated mixture density f̂(z), (2.5), to the count vec-
tor y = (y1, y2, . . . , yK)
′, by maximum likelihood estimation within a para-
metric family such as (4.4). For central matching, log f̂+0 (z), (2.4), is fit to
log f̂(z) as in (4.5)–(4.7); the fitting is by ordinary least squares over a central
subset of K0 bins having index set say “i0.” In Figure 5, f̂(z) was estimated
using K = 41 bins having centerpoints −4.0,−3.8, . . . ,4.0, while log f̂+0 (z)
was fit to log f̂(z) from the K0 = 6 central bins i0 = (18,19,20,21,22,23).
Let X be the K ×m structure matrix used for estimating log f̂(z); X
has m= 8, kth row (1, xk, x
2
k, . . . , x
7
k) in (4.4). Also let X0 be the K ×m0
matrix used to describe log f̂0(z); X0 has kth row (1, xk, x
2
k), m0 = 3 for the
empirical null estimate (4.5), while X0 is the K × 1 matrix (1,1, . . . ,1)′ for
the theoretical null. (Section 7 of [9] considers more ambitious empirical null
estimates, e.g., including a cubic term.)
Define submatrices of X and X0,
X˜ =X[i0, ·] and X˜0 =X0[i0, ·],(5.1)
of dimensions K0 ×m and K0 ×m0; also
ν̂k =N∆f̂(xk), k = 1,2, . . . ,K,(5.2)
an estimate of the expected count in bin k; and
Ĝ=X ′ diag(ν̂)X, G˜0 = X˜
′
0X˜0,(5.3)
where diag(ν̂) is a K × K diagonal matrix having diagonal elements ν̂k.
Finally, let ℓ̂ indicate the K-vector with elements ℓ̂k = log f̂(xk), likewise ℓ̂
+
0
for the vector (log f̂+0 (xk)) and ℓ̂fdr for (log f̂dr(xk)).
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By definition the influence function of vector ℓ̂fdr with respect to count
vector y is the K ×K matrix dℓ̂fdr/dy of partial derivatives ∂ℓ̂fdrk/∂yℓ.
Lemma 1. The influence function of log f̂dr with respect to y, when
using central matching, is
dℓ̂fdr
dy
=AĜ−1X ′,(5.4)
where
A=X0G˜
−1
0 X˜
′
0X˜ −X.(5.5)
Proof. A small change dy in the count vector (considered as continu-
ous) produces the change dℓ̂ in ℓ̂,
dℓ̂=XĜ−1X ′dy.(5.6)
Similarly if ℓ̂
+
0 =X0γ̂, γ̂ an m0-vector, is fit by least squares to ℓ˜= ℓ̂[i0], we
have
dγ̂ = G˜−10 X˜
′
0 dℓ˜ and dℓ̂
+
0 =X0G˜
−1
0 X˜
′
0 dℓ˜.(5.7)
Both (5.6) and (5.7) are standard regression results. Then (5.6) gives dℓ˜=
dℓ̂[i0] = X˜Ĝ
−1X ′ dy, yielding
dℓ̂
+
0 =X0G˜
−1
0 X˜
′
0X˜Ĝ
−1X ′ dy
from (5.7). Finally,
d(ℓ̂fdr) = d(ℓ̂
+
0 − ℓ̂) = (X0Ĝ−10 X˜ ′0X˜ −X)Ĝ−1X ′dy,(5.8)
verifying (5.4). 
Theorem 1. In the case where the z values are independent, the delta-
method estimate of covariance for the vector of log f̂dr(xk) values, based on
central matching, is
ĉov(ℓf̂dr) =AĜ−1A′.(5.9)
Proof. Under independence, y has a multinomial distribution with co-
variance matrix
cov(y) = diag(ν)− νν ′/N,(5.10)
where ν ≡E{y} [νk .=N∆f(xk), as in (5.2)]. The delta-method covariance
estimate is(
dℓ̂fdr
dy
)
ĉov(y)
(
dℓ̂fdr
dy
)′
= (AĜ−1X)diag(ν̂)(AĜ−1X)′
(5.11)
=AĜ−1A′.
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Table 4
Boldface: standard errors of log f̂dr(z), ( “local”), and log F̂dr(z), ( “tail”), 250
replications of model (3.9), N = 1500. Parentheses: average standard deviation estimate
from formula (5.9); fdr is the true false discovery rate (2.6) based on model (3.9).
Natural spline basis, 7 degrees of freedom used to fit f(z), central matching for f̂+0 (z),
empirical null case
Theoretical null Empirical null
z fdr local (formula) tail local (formula) tail
1.5 0.88 0.05 (0.05) 0.05 0.04 (0.04) 0.10
2.0 0.69 0.08 (0.09) 0.05 0.09 (0.10) 0.15
2.5 0.38 0.09 (0.10) 0.05 0.16 (0.16) 0.23
3.0 0.12 0.08 (0.10) 0.06 0.25 (0.25) 0.32
3.5 0.03 0.10 (0.13) 0.07 0.38 (0.38) 0.42
4.0 0.005 0.11 (0.15) 0.10 0.50 (0.51) 0.52
Here we have used (dℓ̂fdr/dy)ν̂ = 0 by homogeneity. As discussed below,
formula (5.9) also has some application to the situation where the z values
are correlated. 
Note. y is an approximation to the order statistic of the z values,
exactly the order statistic if we let bin width ∆→ 0. False discovery rates
only depend upon the order statistic, facilitating compact formulas like (5.9).
A formula similar to (5.11) exists for the tail area false discovery rates
ℓ̂Fdrk = log F̂dr(xk),
ĉov(ℓ̂Fdr) =BĜ−1B′,(5.12)
B = Ŝ0X0G˜
−1
0 X˜
′
0X˜ − ŜX,(5.13)
where, for the case of left-tail F̂dr’s, Ŝ0 and Ŝ are lower triangular matrices,
Ŝkℓ =
f̂ℓ
F̂k
and Ŝ0kℓ =
f̂0ℓ
F̂0k
for ℓ≤ k.(5.14)
Simulation (3.9) for Table 1 was extended to assess the covariance formula
(5.9). Table 4 compares the observed standard deviations of log f̂dr(z), now
from 250 trials, with the average estimates ŝd obtained from the square root
of the diagonal elements of (5.9). The formula is quite accurate, especially
in the empirical null situation; ŝd was reasonably stable from trial to trial,
with coefficient of variation less than 10% for 2.5≤ z ≤ 3.5.
The “fdr” column in Table 4 is fdr(z), (2.6), based on f0(z) ∼ N(0,1),
f1(z) ∼N(3,2) and p0 = 0.9 as implied by model (3.9). Decisions between
22 B. EFRON
null versus nonnull are most difficult in the crucial range 2.5≤ z ≤ 3.5, where
fdr(z) declines from 0.38 to 0.03. The standard errors for local fdr estimates
are about one third again larger than for tail area Fdr, when using the
theoretical null. Both give stable estimates in Table 4: a 10% coefficient of
variation might mean an estimated f̂dr of 0.20±0.02, quite tolerable in most
large-scale testing situations.
Estimation accuracy is much worse on the empirical null side of the ta-
ble: a 25% coefficient of variation translates to uncomfortably variable fdr
estimates such as 0.20± 0.05. Now tail area F̂dr’s are about one third more
variable than local f̂dr’s [and several percent worse still if F (z) in (2.7) is
estimated by the usual empirical c.d.f. rather than the parametric estimate
corresponding to f̂(z)]. Increasing N by factor c decreases standard errors
by roughly
√
c, so taking N = 6000 would about halve the boldface values
in Table 4. Reducing the degrees of freedom for estimating f(z) from 7 to 5
decreased standard errors by about one third. MLE fitting gave about the
same results as central matching here.
“Always use the theoretical null” is not practical advice, even if supple-
mented by permutation methods. The theoretical or permutation null yields
seriously misleading results for the HIV data, as discussed in [10]. Some form
of empirical null estimation seems inevitable here, whether using tail area
or local false discovery rates (or, for that matter, other simultaneous test-
ing techniques). Of course one should strive for the most efficient possible
estimation method, and MLE fitting seems to offer some advantages in this
regard.
The equivalent of Lemma 1 when using MLE fitting is derived from the
likelihood (4.12). Some definitions in addition to (4.9) are needed:
[a, b] =
[−x0− δ0
σ0
,
x0 − δ0
σ0
]
,
Hp(δ0, σ0) =
∫ b
a
zpϕ(z)dz, p= 0,1,2,3,4,
(5.15)
Ep(δ0, σ0) =
σp0
H0
[
Hp+ p
δ0
σ0
Hp−1
+
(
p
2
)(
δ0
σ0
)2
Hp−2 + · · ·+
(
δ0
σ0
)p
H0
]
[where Hp = Hp(δ0, σ0), etc.], and likewise â, b̂, Ĥp, Êp for these quantities
when (δ0, σ0) = (δ̂0, σ̂0).
Conditional on N0, the number of zi values observed in [−x0, x0], the
second factor in (4.12) is a two-parameter exponential family with bivariate
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sufficient statistics
(
Y1
Y2
)
=
1
N0

∑
I0
zi∑
I0
z2i
 .(5.16)
Y has expectation (E1(δ0, σ0),E2(δ0, σ0)) and covariance matrix
V =
1
N0
(
E2 −E21 E3 −E1E2
E3 −E1E2 E4 −E22
)
.(5.17)
By definition, an estimate of f+0 (z) using MLE fitting depends only on
the counts “y0” within [−x0, x0], corresponding say to index set K0, length
K0. Let M0 be the 3×K0 matrix whose kth column equals (1, xk −Y1, x2k−
Y2)
′ for k ∈K0. Straightforward but lengthy exponential family calculations
produce the influence function of ℓ̂
+
0 = (log f̂
+
0 (xk)) with respect to y0, a
K ×K0 matrix,
dℓ̂
+
0
dy0
=
1
NĤ0p̂0
[
1K ·
(
1− N0
N
)
,
Û Ĵ V̂ −1
σ̂0
]
M0,(5.18)
where 1K is a vector of K 1’s, V̂ the estimated version of (5.17),
Ĵ = σ̂20
(
1 2δ20
0 σ̂
)
,(5.19)
and U the K × 2 matrix with kth row
uk =
(
xk − δ̂0
σ̂0
− Ĥ1
Ĥ0
,
(xk − δ̂0)2 − σ̂20
σ̂20
− Ĥ2 − Ĥ0
Ĥ0
)
.(5.20)
Since dℓ̂/dy =XĜ−1X ′ as before, (5.9) and (5.18) combine to give dℓ̂fdr/dy
for MLE fitting:
Lemma 2. The influence function of log f̂dr with respect to y, using
MLE fitting, is the K ×K matrix
dℓ̂fdr
dy
=
1
NĤ0p̂0
[
1 ·
(
1− N0
N
)
,
Û Ĵ V̂ −1
σ̂0
]
M −XĜ−1X ′,(5.21)
where M is the 3×K matrix with kth column (1, xk−Y1, x2k−Y2)′ for k ∈K0,
and (0,0,0)′ for k /∈K0.
Delta-method estimates of cov(ℓf̂dr) for MLE fitting are obtained from
Lemma 2 as in (5.11), though the formula does not collapse neatly as in
(5.9). We can employ Lemmas 1 and 2 to compare central matching with
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Fig. 6. Left panel : Influence curves d log f̂dr(3.45)/dyk for prostate data, central match-
ing (solid) and MLE fitting (beaded); plotted versus bin centerpoints xk. Right panel: vari-
ance spectra (5.22); MLE has less area, smaller stdev estimate.
MLE fitting for the sensitivity of F̂dr(z) to changes in the count vector y.
The left panel of Figure 6 compares the two influence functions d log f̂dr(z =
3.45)/dyk , plotted versus bin centerpoint xk, k = 1,2, . . . ,K, for the prostate
data [z = 3.45 has f̂dr(z)
.
= 0.2 for both empirical methods, rather than
f̂dr(3.37) = 0.2 using the theoretical null]. MLE fitting used x0 = 2 in (4.8),
accounting for the discontinuities there in its influence curve. The right panel
shows the “variance spectrum”
Sk(z) =
(
d log f̂dr(z)
dyk
)2
ν̂k, k = 1,2, . . . ,K,(5.22)
ν̂k the estimated expectation of yk, (5.2). The delta-method estimate of the
standard deviation for log f̂dr(z) is
ŝd(z) =
(
K∑
k=1
Sk(z)
)1/2
(5.23)
as in (5.11), so variance is proportional to the area under the curve. In this
case, MLE fitting has less area and smaller estimated standard deviation.
If we were to use an empirical null here, rather than the theoretical null of
Figure 3, this would argue for MLE fitting.
Let ξ̂ = (p̂0, δ̂0, σ̂0). Results similar to Lemma 1 and Theorem 1 yield
closed-form expressions for the delta-method estimate of cov(ξ̂). For central
matching,
ĉov(ξ̂) =DĜ−1D′−E,(5.24)
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E a 3× 3 matrix with E11 = 1/N and all other entries 0, and
D=
1 δ̂ σ̂2 + δ̂20 σ̂2 2δ̂σ̂2
0 0 σ̂3
 G˜−10 X˜ ′0X˜,(5.25)
Ĝ, G˜0, X˜0 and X˜ as in (5.1), (5.3).
The corresponding estimate of cov(ξ̂) using MLE fitting is
ĉov(ξ̂) = aba′,(5.26)
with a and b both 3× 3 matrices,
a=
(
1/Ĥ0, c
′
0 I2
)
, c′ =− p̂0
σ̂0
(
Ĥ1
Ĥ0
,
Ĥ2 − Ĥ0
Ĥ0
)
,(5.27)
and
b=
(
p̂0Ĥ0(1− p̂0Ĥ0/N), 0′
0, Ĵ V̂ −1Ĵ/N0
)
,(5.28)
Ĵ and V̂ as in (5.17), (5.19). Locfdr returns the standard deviation estimates
of p̂0, δ̂0 and σ̂0 based on (5.24) and (5.26).
Model (3.9) presumes that the null genes are exactly null. Figure 7 is
based on a more relaxed model:
zi
ind∼ N(µi,1) with
{
µi ∼N(0,0.52), probability 0.90,
µi ∼N(3,1), probability 0.10,(5.29)
i = 1,2, . . . ,N = 1500. In an observational study this might reflect unob-
served covariates that jitter even the null cases, as in Section 4 of [8]. In
terms of the two-class model (2.2), (5.29) amounts to p0 = 0.90,
f0(z)∼N(0,1.122) and f1(z)∼N(3,2).(5.30)
Using the theoretical N(0,1) null in situation (5.29) gives misleading re-
sults: f̂dr(z) tends to be far too liberal in diagnosing nonnull genes, as shown
by the beaded curve in Figure 7. Empirical null estimation gives f̂dr(z) es-
timates much closer to the true curve fdr(z) = p0f0(z)/f(z) from (5.30).
This just says the obvious: empirical methodology correctly estimates f0(z)
in (5.30) [central matching gave (δ̂0, σ̂0) estimates averaging (0.02,1.14)],
which is the whole point of using empirical nulls. Section 4 of [8] discusses
what “the correct null” means in this situation, and why it cannot be found
by the usual permutation methods.
Our covariance estimates, such as (5.9), were derived assuming indepen-
dence among the components of z = (z, z2, . . . , zN ) (almost true for the
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Fig. 7. Average local false discovery rates f̂dr(z), 250 replications of (5.29): heavy curve
using empirical null; beaded curve theoretical null; dots true fdr, (2.6) and (5.30). Using
the theoretical null yields far too many nonnull genes, including some for zi < 0.
prostate data but not the HIV data). However the influence function for-
mulas have a wider range of applicability. The delta-method estimate of
covariance
ĉov(ℓ̂fdr) = (dℓ̂fdr/dy)ĉov(y)(dℓ̂fdr/dy)′(5.31)
applies just as well to correlated zi’s. What changes is that (5.10) no longer
represents cov(y).
The development in Section 3 of [10] suggests that the estimate
ĉov(y) = diag(ν̂),(5.32)
with ν̂k =N∆f̂(xk) as in (5.2), is still appropriate in a conditional sense for
the correlated case. Speaking broadly, employing an empirical null amounts
to conditioning the estimate f̂dr(z) on an approximate ancillary statistic
(“A” in [10]), after which (5.31) and (5.32) gives the appropriate conditional
covariance. This amounts to using (5.9), or its equivalent for MLE fitting,
as stated. More careful estimates of ĉov(y) in (5.3) are available in the
correlated z situation, but the formulas of this section are at least roughly
applicable, especially for comparing different estimation techniques.
6. Summary. Large-scale simultaneous testing situations, with thousands
of hypothesis tests to perform at the same time, are illustrated by the two
microarray studies of Figure 1. False discovery rate methods facilitate both
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size and power calculations, as discussed in Sections 2 and 3, bringing em-
pirical Bayes ideas to bear on simultaneous inference problems. Two types
of false discovery rate statistics are analyzed, the more familiar tail area
Fdr’s introduced by Benjamini and Hochberg [3], and local fdr’s, which are
better suited for Bayesian interpretation. Power diagnostics may show, as
in our examples, that a majority of the nonnull cases cannot be reported
as “interesting” to the investigators without including an unacceptably high
proportion of null cases.
Fdr methods, either local or tail area, are easy to apply when the ap-
propriate null distribution is known to the statistician from theoretical or
permutation considerations. However, it may be clear that the theoreti-
cal/permutation null is incorrect, as with the second histogram of Figure
1. Section 4 gives four reasons why this might happen, especially in observa-
tional studies. Two methods of estimating an “empirical null” distribution
are presented, and formulas for their accuracy derived in Section 5. Using an
empirical null decreases the accuracy of false discovery rate methods, both
local and tail area, but is unavoidable in situations like the second microar-
ray study. Software in R, locfdr, is available through CRAN for carrying out
all the fdr size and power calculations.
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